We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
-$30M
Cap. Flow
-$21.6M
Cap. Flow %
-15.92%
Top 10 Hldgs %
25.49%
Holding
262
New
34
Increased
55
Reduced
87
Closed
45

Top Buys

Rank Stock Value
1
ENOV icon
Enovis
ENOV
+$1.04M
2
AMPH icon
Amphastar Pharmaceuticals
AMPH
+$1.04M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$958K
4
QQQM icon
Invesco NASDAQ 100 ETF
QQQM
+$955K
5
SRPT icon
Sarepta Therapeutics
SRPT
+$929K

Top Sells

Rank Stock Value
1
URGN icon
UroGen Pharma
URGN
+$2.16M
2
CORT icon
Corcept Therapeutics
CORT
+$2.14M
3
NARI
Inari Medical, Inc. Common Stock
NARI
+$2.13M
4
KALV
KalVista Pharmaceuticals
KALV
+$1.49M
5
CATX icon
Perspective Therapeutics
CATX
+$1.35M

Sector Composition

Rank Sector Weight
1 Healthcare 60.25%
2 Real Estate 12.98%
3 Financials 6.42%
4 Industrials 2.59%
5 Technology 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EG icon
101
Everest Group
EG
$15.1B
$251K 0.18%
659
+14
+2% +$5.29K
PR
102
Permian Resources
PR
$16.9B
$245K 0.18%
15,168
+7,683
+103% +$127K
GILD icon
103
Gilead Sciences
GILD
$167B
$240K 0.18%
3,500
– –
SHYG icon
104
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$236K 0.17%
5,599
-6
-0.1% -$253
HYGV icon
105
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.1B
$236K 0.17%
5,843
+41
+0.7% +$1.66K
JNK icon
106
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.36B
$236K 0.17%
2,504
-7
-0.3% -$658
GHYG icon
107
iShares US & Intl High Yield Corp Bond ETF
GHYG
$185M
$235K 0.17%
5,370
-45
-0.8% -$1.96K
FALN icon
108
iShares Fallen Angels USD Bond ETF
FALN
$1.64B
$234K 0.17%
8,936
-17
-0.2% -$448
IMTX icon
109
Immatics
IMTX
$1.31B
$232K 0.17%
20,000
+2,500
+14% +$28.2K
SAFE
110
Safehold
SAFE
$1.22B
$231K 0.17%
11,972
– –
KGC icon
111
Kinross Gold
KGC
$27B
$223K 0.16%
26,828
+15,806
+143% +$114K
CPRT icon
112
Copart
CPRT
$25.6B
$215K 0.16%
3,966
+21
+0.5% +$1.15K
AJG icon
113
Arthur J. Gallagher & Co
AJG
$65.2B
$203K 0.15%
783
+6
+0.8% +$1.49K
DVA icon
114
DaVita
DVA
$15.2B
$201K 0.15%
1,451
+623
+75% +$85.9K
ROP icon
115
Roper Technologies
ROP
$36.6B
$198K 0.15%
351
+2
+0.6% +$1.08K
BR icon
116
Broadridge
BR
$17.3B
$195K 0.14%
990
+10
+1% +$1.98K
THC icon
117
Tenet Healthcare
THC
$16.8B
$195K 0.14%
1,466
+584
+66% +$70.3K
V icon
118
Visa
V
$682B
$193K 0.14%
737
+5
+0.7% +$1.37K
PHM icon
119
Pultegroup
PHM
$24B
$191K 0.14%
1,733
-1,399
-45% -$159K
APH icon
120
Amphenol
APH
$186B
$191K 0.14%
+2,832
New +$179K
CTAS icon
121
Cintas
CTAS
$81.8B
$190K 0.14%
+1,084
New +$185K
TJX icon
122
TJX Companies
TJX
$171B
$190K 0.14%
+1,722
New +$173K
MCK icon
123
McKesson
MCK
$98.5B
$184K 0.14%
315
+110
+54% +$61.2K
BRO icon
124
Brown & Brown
BRO
$23.5B
$183K 0.13%
+2,049
New +$178K
TMUS icon
125
T-Mobile US
TMUS
$208B
$181K 0.13%
+1,029
New +$173K
3 4
5
6 7

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, AlphaCentric Advisors held 262 positions worth $136M, down 18% from $166M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

AlphaCentric Advisors withdrew a net $21.6M in Q2 2024, closing 45 positions and reducing 87 holdings. Its most notable exit was UroGen Pharma, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 61% a quarter earlier, followed by Real Estate and Financials.

Against the trend, AlphaCentric Advisors opened a new position in Enovis worth $904K.

  • AlphaCentric Advisors's largest Q2 2024 buy was Enovis: 20,000 shares worth $904K.
  • AlphaCentric Advisors added most to Invesco QQQ Trust in Q2 2024, an estimated $958K increase.
  • AlphaCentric Advisors's biggest Q2 2024 reduction was Inari Medical, Inc. Common Stock, cutting an estimated $2.13M.
  • AlphaCentric Advisors fully exited UroGen Pharma in Q2 2024, selling an estimated $2.16M.
  • AlphaCentric Advisors's ten largest holdings make up 25% of its $136M portfolio in Q2 2024.
  • AlphaCentric Advisors opened 34 new positions and closed 45 in Q2 2024.
  • AlphaCentric Advisors's portfolio value fell 18% quarter-over-quarter to $136M.

Based on AlphaCentric Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.